GoodRx and GEO Group Top Expectations, Outlook Miss
- August 09th, 2023
- 480 views
GoodRx Holdings, Inc. (Nasdaq: GDRX) revealed second-quarter 2023 adjusted earnings of $0.07 per share, surpassing the consensus EPS estimate of $0.06. The company's quarterly sales amounted to $189.70 million, slightly exceeding the analysts' projected revenue of $186.82 million. However, GoodRx anticipates Q3 revenue to range between approximately $186 million and $190 million, contrasting with the consensus estimate of $192.58 million for the period.
$GDRX was trading at $8.65 in pre-market, reflecting a decrease of $0.09 (-1.03%).
Shifting focus, The GEO Group, Inc. (NYSE: GEO) reported earnings of $0.24 per share for Q2 2023, surpassing the consensus EPS estimate of $0.20. The company's quarterly revenues reached $593.90 million, exceeding the analysts' expected revenue of $588.26 million. GEO Group projects full-year 2023 revenues around $2.4 billion, slightly below the consensus estimate of $2.43 billion for the period.
In pre-market, $GEO was trading at $7.02, down $0.26 (-3.57%).
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
DOT, DoW, DHS Join Forces to Protect Southern Border Airspace
October 16th, 2026FTC Sues Ticket Broker Over Unlawful Tactics Used to Buy Millions of Tickets to Popular Live Events
October 15th, 2026October 15th, 2026FDA Approves First Treatment for Certain People With BCG-Unresponsive Bladder Cancer
October 14th, 2026U.S. Treasury Announces Record Enforcement Actions Against Bank of America
October 14th, 2026
Member Login